Literature DB >> 1662775

Release of noradrenaline and ATP by electrical stimulation and nicotine in guinea-pig vas deferens.

I von Kügelgen1, K Starke.   

Abstract

Effects of electrical stimulation and nicotine on ATP and tritium outflow and smooth muscle tension were studied in the guinea-pig isolated vas deferens preincubated with [3H]-noradrenaline. ATP was measured using the luciferase technique. Electrical stimulation caused biphasic contractions and an acceleration of ATP and tritium outflow. The contraction amplitude and the overflow of ATP increased markedly, whereas the overflow of tritium increased only slightly with the frequency of stimulation (1-10 Hz; constant number of 60 pulses). The contraction amplitude did not increase with an increase in pulse number (20-540 pulses; constant frequency of 5 Hz), whereas the overflow of ATP increased slightly, and that of tritium markedly. Nicotine caused monophasic, transient contractions and, again, an acceleration of ATP and tritium outflow. Contractions, ATP and tritium overflow increased with the concentration of nicotine (56-320 mumol/l) in an approximately parallel manner. The influence of some drugs on responses to electrical stimulation (60 pulses, 5 Hz) and nicotine (180 mumol/l) was investigated. Tetrodotoxin blocked all effects of electrical stimulation but did not change those of nicotine. The reverse was true for hexamethonium. Neither electrical stimulation nor nicotine caused contraction or an increase in ATP outflow after pretreatment with 6-hydroxydopamine. The main effects of prazosin 0.3 mumol/l were to reduce electrically evoked contractions (above all second phase) as well as nicotine-evoked contractions and the nicotine-evoked overflow of ATP (the latter by about 81%). Prazosin also tended to diminish the electrically evoked overflow of ATP. alpha,beta-Methylene-ATP 10 mumol/l elicited a transient contraction and ATP overflow on its own. The main change in the subsequent state of desensitization was a decrease of the first phase of electrically evoked contractions. The main effects of prazosin combined with desensitization by alpha,beta-methylene-ATP were marked decreases of electrically evoked contractions (by 94%), the electrically evoked overflow ATP (by 66%), nicotine-evoked contractions (by 97%) and the nicotine-evoked overflow of ATP (by 70%). It is concluded that both electrical stimulation and nicotine release noradrenaline and ATP in guinea-pig vas deferens. Only part of the evoked overflow of ATP (about 32%) is neural in origin. Another part probably originates from smooth muscle cells where it is released by neurogenic noradrenaline acting at alpha 1-adrenoceptors. Corelease leads to cotransmission: electrically as well as nicotine-evoked contractions consist of adrenergic and purinergic components. Varying types of stimulation release cotransmitter mixtures of varying composition.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662775     DOI: 10.1007/BF00172581

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

1.  Autoradiographic study of the rat vas deferens incubated with 3H-noradrenaline.

Authors:  I Azevedo; D Moura; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Autoinhibition of nicotinic release of noradrenaline from postganglionic sympathetic nerves.

Authors:  K Löffelholz
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

3.  Blockade of the nicotine-induced norepinephrine release by cocaine, phenoxybenzamine and desipramine.

Authors:  C Su; J A Bevan
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

4.  Sympathetic nerve-mediated release of ATP from the guinea-pig vas deferens is unaffected by reserpine.

Authors:  K Kirkpatrick; G Burnstock
Journal:  Eur J Pharmacol       Date:  1987-06-19       Impact factor: 4.432

5.  A possible coupling of postjunctional ATP release and transmitters' receptor stimulation in smooth muscles.

Authors:  T Katsuragi; T Tokunaga; S Usune; T Furukawa
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

6.  Origin of adenosine released from rat vas deferens by nerve stimulation.

Authors:  B B Fredholm; G Fried; P Hedqvist
Journal:  Eur J Pharmacol       Date:  1982-04-23       Impact factor: 4.432

7.  Norepinephrine and adenosine triphosphate release in different ratio from guinea pig vas deferens by high potassium chloride, ouabain and monensin.

Authors:  T Katsuragi; T Tokunaga; K Miyamoto; L Kuratomi; T Furukawa
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

8.  Alpha 2-adrenoceptor-mediated autoinhibition of sympathetic transmitter release in guinea-pig vas deferens studied by intracellular and focal extracellular recording of junction potentials and currents.

Authors:  J A Brock; T C Cunnane; K Starke; C F Wardell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

9.  Contribution by purines to the neurogenic response of the vas deferens of the guinea pig.

Authors:  J S Fedan; G K Hogaboom; J P O'Donnell; J Colby; D P Westfall
Journal:  Eur J Pharmacol       Date:  1981-01-05       Impact factor: 4.432

10.  Acetylcholine releases ATP from varicosities isolated from guinea pig myenteric plexus.

Authors:  T D White; M Al-Humayyd
Journal:  J Neurochem       Date:  1983-04       Impact factor: 5.372

View more
  32 in total

1.  Distinct mechanisms underlying alpha1-adrenoceptor and P2x purinoceptor operated ATP release and contraction in the guinea-pig vas deferens.

Authors:  B Sperlágh; P Illes; Z Gerevich; A Köfalvi
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 2.  Neurotransmitter release mechanisms in sympathetic neurons: past, present, and future perspectives.

Authors:  V M Jackson; T C Cunnane
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

3.  Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens.

Authors:  L D Todorov; S Mihaylova-Todorova; G L Craviso; R A Bjur; D P Westfall
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

4.  Potentiation of sympathetic neuromuscular transmission mediated by muscarinic receptors in guinea pig isolated vas deferens.

Authors:  Samera Iram; Charles H V Hoyle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04-05       Impact factor: 3.000

5.  The fade of the purinergic neurogenic contraction of the guinea-pig vas deferens: analysis of possible mechanisms.

Authors:  B Driessen; I von Kügelgen; R Bültmann; D B Elrick; T C Cunnane; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

6.  Cholinergic innervation of the guinea-pig isolated vas deferens.

Authors:  Pravesh Solanki; Alina M Cuprian-Beltechi; Thomas C Cunnane
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-09       Impact factor: 3.000

7.  Release of ATP in rat vas deferens: origin and role of calcium.

Authors:  A K Kurz; R Bültmann; B Driessen; I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

8.  Comparison of corelease of noradrenaline and ATP evoked by hypogastric nerve stimulation and field stimulation in guinea-pig vas deferens.

Authors:  J Gonçalves; B Driessen; I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

9.  Modulation of neural noradrenaline and ATP release by angiotensin II and prostaglandin E2 in guinea-pig vas deferens.

Authors:  B Driessen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-12       Impact factor: 3.000

10.  Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries.

Authors:  Shinji Eguchi; Satoko Tezuka; Narumi Hobara; Shinji Akiyama; Yuji Kurosaki; Hiromu Kawasaki
Journal:  Br J Pharmacol       Date:  2004-07-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.